Clinical Trial

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A research study of house dust mite (HDM) SLIT-tablet for the treatment of HDM allergy in Chinese participants aged 12-65.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-02
notable Primary completion pushed: 2026-07 -> 2026-09-06 2026-06-02
minor Completion pushed: 2026-08 -> 2026-09-13 2026-06-02
Trial Details
NCT Number NCT07060885
Lead Sponsor ALK-Abelló A/S
Collaborators: Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Allergic Rhinoconjunctivitis, Allergic Rhinitis
Enrollment 327 participants
Start Date 2025-09-01
Primary Completion 2026-09-06 (estimated)
Study Completion 2026-09-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-20